Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 2000 Apr 24;66(6):1766–1776. doi: 10.1086/302930

COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS.

R J Wenstrup 1, J B Florer 1, M C Willing 1, C Giunta 1, B Steinmann 1, F Young 1, M Susic 1, W G Cole 1
PMCID: PMC1378044  PMID: 10777716

Abstract

We have identified haploinsufficiency of the COL5A1 gene that encodes the proalpha1(V) chain of type V collagen in the classical form of the Ehlers-Danlos syndrome (EDS), a heritable connective-tissue disorder that severely alters the collagen-fibrillar structure of the dermis, joints, eyes, and blood vessels. Eight of 28 probands with classical EDS who were heterozygous for expressed polymorphisms in COL5A1 showed complete or nearly complete loss of expression of one COL5A1 allele. Reduced levels of proalpha1(V) mRNA relative to the levels of another type V collagen mRNA, proalpha2(V), were also observed in the cultured fibroblasts from EDS probands. Products of the two COL5A1 alleles were approximately equal after the addition of cycloheximide to the fibroblast cultures. After harvesting of mRNAs from cycloheximide-treated cultured fibroblasts, heteroduplex analysis of overlapping reverse transcriptase-PCR segments spanning the complete proalpha1(V) cDNA showed anomalies in four of the eight probands that led to identification of causative mutations, and, in the remaining four probands, targeting of CGA-->TGA mutations in genomic DNA revealed a premature stop at codon in one of them. We estimate that approximately one-third of individuals with classical EDS have mutations of COL5A1 that result in haploinsufficiency. These findings indicate that the normal formation of the heterotypic collagen fibrils that contain types I, III, and V collagen requires the expression of both COL5A1 alleles.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abedin M. Z., Ayad S., Weiss J. B. Type V collagen: the presence of appreciable amounts of alpha 3(V) chain in uterus. Biochem Biophys Res Commun. 1981 Oct 30;102(4):1237–1245. doi: 10.1016/s0006-291x(81)80144-1. [DOI] [PubMed] [Google Scholar]
  2. Andrikopoulos K., Liu X., Keene D. R., Jaenisch R., Ramirez F. Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet. 1995 Jan;9(1):31–36. doi: 10.1038/ng0195-31. [DOI] [PubMed] [Google Scholar]
  3. Andrikopoulos K., Suzuki H. R., Solursh M., Ramirez F. Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. Dev Dyn. 1992 Oct;195(2):113–120. doi: 10.1002/aja.1001950205. [DOI] [PubMed] [Google Scholar]
  4. Ashhurst D. E., Bland Y. S., Levick J. R. An immunohistochemical study of the collagens of rabbit synovial interstitium. J Rheumatol. 1991 Nov;18(11):1669–1672. [PubMed] [Google Scholar]
  5. Barabas A. P. Heterogeneity of the Ehlers-Danlos syndrome: description of three clinical types and a hypothesis to explain the basic defect(s). Br Med J. 1967 Jun 3;2(5552):612–613. doi: 10.1136/bmj.2.5552.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beighton P., De Paepe A., Steinmann B., Tsipouras P., Wenstrup R. J. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998 Apr 28;77(1):31–37. doi: 10.1002/(sici)1096-8628(19980428)77:1<31::aid-ajmg8>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  7. Beighton P., de Paepe A., Danks D., Finidori G., Gedde-Dahl T., Goodman R., Hall J. G., Hollister D. W., Horton W., McKusick V. A. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet. 1988 Mar;29(3):581–594. doi: 10.1002/ajmg.1320290316. [DOI] [PubMed] [Google Scholar]
  8. Belgrader P., Cheng J., Zhou X., Stephenson L. S., Maquat L. E. Mammalian nonsense codons can be cis effectors of nuclear mRNA half-life. Mol Cell Biol. 1994 Dec;14(12):8219–8228. doi: 10.1128/mcb.14.12.8219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Birk D. E., Fitch J. M., Babiarz J. P., Linsenmayer T. F. Collagen type I and type V are present in the same fibril in the avian corneal stroma. J Cell Biol. 1988 Mar;106(3):999–1008. doi: 10.1083/jcb.106.3.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brown R. A., Shuttleworth C. A., Weiss J. B. Three new alpha-chains of collagen from a non-basement membrane source. Biochem Biophys Res Commun. 1978 Feb 28;80(4):866–872. doi: 10.1016/0006-291x(78)91324-4. [DOI] [PubMed] [Google Scholar]
  11. Brown R. A., Weiss J. B. Type V collagen: possible shared identity of alpha A, alpha B and alpha C chains. FEBS Lett. 1979 Oct 1;106(1):71–75. doi: 10.1016/0014-5793(79)80697-3. [DOI] [PubMed] [Google Scholar]
  12. Burch G. H., Gong Y., Liu W., Dettman R. W., Curry C. J., Smith L., Miller W. L., Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet. 1997 Sep;17(1):104–108. doi: 10.1038/ng0997-104. [DOI] [PubMed] [Google Scholar]
  13. Burrows N. P., Nicholls A. C., Richards A. J., Luccarini C., Harrison J. B., Yates J. R., Pope F. M. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families. Am J Hum Genet. 1998 Aug;63(2):390–398. doi: 10.1086/301948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Burrows N. P., Nicholls A. C., Yates J. R., Gatward G., Sarathachandra P., Richards A., Pope F. M. The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. J Invest Dermatol. 1996 Jun;106(6):1273–1276. doi: 10.1111/1523-1747.ep12348978. [DOI] [PubMed] [Google Scholar]
  15. Carter M. S., Doskow J., Morris P., Li S., Nhim R. P., Sandstedt S., Wilkinson M. F. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem. 1995 Dec 1;270(48):28995–29003. doi: 10.1074/jbc.270.48.28995. [DOI] [PubMed] [Google Scholar]
  16. Danielson K. G., Baribault H., Holmes D. F., Graham H., Kadler K. E., Iozzo R. V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997 Feb 10;136(3):729–743. doi: 10.1083/jcb.136.3.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. De Paepe A., Nuytinck L., Hausser I., Anton-Lamprecht I., Naeyaert J. M. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet. 1997 Mar;60(3):547–554. [PMC free article] [PubMed] [Google Scholar]
  18. Delacoux F., Fichard A., Geourjon C., Garrone R., Ruggiero F. Molecular features of the collagen V heparin binding site. J Biol Chem. 1998 Jun 12;273(24):15069–15076. [PubMed] [Google Scholar]
  19. Fleischmajer R., Fisher L. W., MacDonald E. D., Jacobs L., Jr, Perlish J. S., Termine J. D. Decorin interacts with fibrillar collagen of embryonic and adult human skin. J Struct Biol. 1991 Feb;106(1):82–90. doi: 10.1016/1047-8477(91)90065-5. [DOI] [PubMed] [Google Scholar]
  20. Giunta C., Steinmann B. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability? Am J Med Genet. 2000 Jan 3;90(1):72–79. doi: 10.1002/(sici)1096-8628(20000103)90:1<72::aid-ajmg13>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  21. Greenspan D. S., Cheng W., Hoffman G. G. The pro-alpha 1(V) collagen chain. Complete primary structure, distribution of expression, and comparison with the pro-alpha 1(XI) collagen chain. J Biol Chem. 1991 Dec 25;266(36):24727–24733. [PubMed] [Google Scholar]
  22. Greenspan D. S., Northrup H., Au K. S., McAllister K. A., Francomano C. A., Wenstrup R. J., Marchuk D. A., Kwiatkowski D. J. COL5A1: fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II. Genomics. 1995 Feb 10;25(3):737–739. doi: 10.1016/0888-7543(95)80021-d. [DOI] [PubMed] [Google Scholar]
  23. Greenspan D. S., Pasquinelli A. E. BstUI and DpnII RFLPs at the COL5A1 gene. Hum Mol Genet. 1994 Feb;3(2):385–385. doi: 10.1093/hmg/3.2.385-a. [DOI] [PubMed] [Google Scholar]
  24. Hausser I., Anton-Lamprecht I. Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification. Hum Genet. 1994 Apr;93(4):394–407. doi: 10.1007/BF00201664. [DOI] [PubMed] [Google Scholar]
  25. Imamura Y., Scott I. C., Greenspan D. S. The pro-alpha3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains. J Biol Chem. 2000 Mar 24;275(12):8749–8759. doi: 10.1074/jbc.275.12.8749. [DOI] [PubMed] [Google Scholar]
  26. Kyriakides T. R., Zhu Y. H., Smith L. T., Bain S. D., Yang Z., Lin M. T., Danielson K. G., Iozzo R. V., LaMarca M., McKinney C. E. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol. 1998 Jan 26;140(2):419–430. doi: 10.1083/jcb.140.2.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Körkkö J., Ala-Kokko L., De Paepe A., Nuytinck L., Earley J., Prockop D. J. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations. Am J Hum Genet. 1998 Jan;62(1):98–110. doi: 10.1086/301689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Leeds P., Wood J. M., Lee B. S., Culbertson M. R. Gene products that promote mRNA turnover in Saccharomyces cerevisiae. Mol Cell Biol. 1992 May;12(5):2165–2177. doi: 10.1128/mcb.12.5.2165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lui V. C., Kong R. Y., Nicholls J., Cheung A. N., Cheah K. S. The mRNAs for the three chains of human collagen type XI are widely distributed but not necessarily co-expressed: implications for homotrimeric, heterotrimeric and heterotypic collagen molecules. Biochem J. 1995 Oct 15;311(Pt 2):511–516. doi: 10.1042/bj3110511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Marchant J. K., Hahn R. A., Linsenmayer T. F., Birk D. E. Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology. J Cell Biol. 1996 Dec;135(5):1415–1426. doi: 10.1083/jcb.135.5.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mayne R., Brewton R. G., Mayne P. M., Baker J. R. Isolation and characterization of the chains of type V/type XI collagen present in bovine vitreous. J Biol Chem. 1993 May 5;268(13):9381–9386. [PubMed] [Google Scholar]
  32. Michalickova K., Susic M., Willing M. C., Wenstrup R. J., Cole W. G. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. Hum Mol Genet. 1998 Feb;7(2):249–255. doi: 10.1093/hmg/7.2.249. [DOI] [PubMed] [Google Scholar]
  33. Moradi-Améli M., Rousseau J. C., Kleman J. P., Champliaud M. F., Boutillon M. M., Bernillon J., Wallach J., Van der Rest M. Diversity in the processing events at the N-terminus of type-V collagen. Eur J Biochem. 1994 May 1;221(3):987–995. doi: 10.1111/j.1432-1033.1994.tb18815.x. [DOI] [PubMed] [Google Scholar]
  34. Moursi A. M., Globus R. K., Damsky C. H. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci. 1997 Sep;110(Pt 18):2187–2196. doi: 10.1242/jcs.110.18.2187. [DOI] [PubMed] [Google Scholar]
  35. Nicholls A. C., Oliver J. E., McCarron S., Harrison J. B., Greenspan D. S., Pope F. M. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome. J Med Genet. 1996 Nov;33(11):940–946. doi: 10.1136/jmg.33.11.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Niyibizi C., Eyre D. R. Identification of the cartilage alpha 1(XI) chain in type V collagen from bovine bone. FEBS Lett. 1989 Jan 2;242(2):314–318. doi: 10.1016/0014-5793(89)80492-2. [DOI] [PubMed] [Google Scholar]
  37. Ohh M., Takei F. Regulation of ICAM-1 mRNA stability by cycloheximide: role of serine/threonine phosphorylation and protein synthesis. J Cell Biochem. 1995 Oct;59(2):202–213. doi: 10.1002/jcb.240590210. [DOI] [PubMed] [Google Scholar]
  38. Pulak R., Anderson P. mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev. 1993 Oct;7(10):1885–1897. doi: 10.1101/gad.7.10.1885. [DOI] [PubMed] [Google Scholar]
  39. Pöschl A., von der Mark K. Synthesis of type V collagen by chick corneal fibroblasts in vivo and in vitro. FEBS Lett. 1980 Jun 16;115(1):100–104. doi: 10.1016/0014-5793(80)80735-6. [DOI] [PubMed] [Google Scholar]
  40. Rao P., Mufson R. A. Interleukin-3 inhibits cycloheximide induction of C-jun mRNA in human monocytes: possible role for a serine/threonine phosphatase. J Cell Physiol. 1993 Sep;156(3):560–566. doi: 10.1002/jcp.1041560315. [DOI] [PubMed] [Google Scholar]
  41. Rhodes R. K., Miller E. J. Evidence for the existence of an alpha 1(V) alpha 2(V) alpha 3(V) collagen molecule in human placental tissue. Coll Relat Res. 1981 Jul;1(4):337–343. doi: 10.1016/s0174-173x(81)80010-6. [DOI] [PubMed] [Google Scholar]
  42. Richards A. J., Martin S., Nicholls A. C., Harrison J. B., Pope F. M., Burrows N. P. A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II. J Med Genet. 1998 Oct;35(10):846–848. doi: 10.1136/jmg.35.10.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sage H., Bornstein P. Characterization of a novel collagen chain in human placenta and its relation to AB collagen. Biochemistry. 1979 Aug 21;18(17):3815–3822. doi: 10.1021/bi00584a027. [DOI] [PubMed] [Google Scholar]
  44. Sage H., Pritzl P., Bornstein P. Susceptibility of type V collagen to neutral proteases: evidence that the major molecular species is a thrombin-sensitive heteropolymer, [alpha 1(V)]2 alpha 2(V). Biochemistry. 1981 Jun 23;20(13):3778–3784. doi: 10.1021/bi00516a017. [DOI] [PubMed] [Google Scholar]
  45. Sokolov B. P., Prytkov A. N., Tromp G., Knowlton R. G., Prockop D. J. Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family. Hum Genet. 1991 Dec;88(2):125–129. doi: 10.1007/BF00206058. [DOI] [PubMed] [Google Scholar]
  46. Sponseller P. D., Tomek I. M., Pyertiz R. E. Developmental dysplasia of the hip in Marfan syndrome. J Pediatr Orthop B. 1997 Oct;6(4):255–259. doi: 10.1097/01202412-199710000-00007. [DOI] [PubMed] [Google Scholar]
  47. Svensson L., Aszódi A., Reinholt F. P., Fässler R., Heinegård D., Oldberg A. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem. 1999 Apr 2;274(14):9636–9647. doi: 10.1074/jbc.274.14.9636. [DOI] [PubMed] [Google Scholar]
  48. Takahara K., Hoffman G. G., Greenspan D. S. Complete structural organization of the human alpha 1 (V) collagen gene (COL5A1): divergence from the conserved organization of other characterized fibrillar collagen genes. Genomics. 1995 Oct 10;29(3):588–597. doi: 10.1006/geno.1995.9961. [DOI] [PubMed] [Google Scholar]
  49. Takahara K., Sato Y., Okazawa K., Okamoto N., Noda A., Yaoi Y., Kato I. Complete primary structure of human collagen alpha 1 (V) chain. J Biol Chem. 1991 Jul 15;266(20):13124–13129. [PubMed] [Google Scholar]
  50. Toriello H. V., Glover T. W., Takahara K., Byers P. H., Miller D. E., Higgins J. V., Greenspan D. S. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet. 1996 Jul;13(3):361–365. doi: 10.1038/ng0796-361. [DOI] [PubMed] [Google Scholar]
  51. Vogel A., Holbrook K. A., Steinmann B., Gitzelmann R., Byers P. H. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab Invest. 1979 Feb;40(2):201–206. [PubMed] [Google Scholar]
  52. Wenstrup R. J., Langland G. T., Willing M. C., D'Souza V. N., Cole W. G. A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet. 1996 Nov;5(11):1733–1736. doi: 10.1093/hmg/5.11.1733. [DOI] [PubMed] [Google Scholar]
  53. Willing M. C., Deschenes S. P., Scott D. A., Byers P. H., Slayton R. L., Pitts S. H., Arikat H., Roberts E. J. Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet. 1994 Oct;55(4):638–647. [PMC free article] [PubMed] [Google Scholar]
  54. Willing M. C., Pruchno C. J., Byers P. H. Molecular heterogeneity in osteogenesis imperfecta type I. Am J Med Genet. 1993 Jan 15;45(2):223–227. doi: 10.1002/ajmg.1320450214. [DOI] [PubMed] [Google Scholar]
  55. Woodley D. T., Scheidt V. J., Reese M. J., Paller A. S., Manning T. O., Yoshiike T., Briggaman R. A. Localization of the alpha 3 (V) chain of type V collagen in human skin. J Invest Dermatol. 1987 Mar;88(3):246–252. doi: 10.1111/1523-1747.ep12465467. [DOI] [PubMed] [Google Scholar]
  56. Wordsworth B. P., Ogilvie D. J., Sykes B. C. Segregation analysis of the structural genes of the major fibrillar collagens provides further evidence of molecular heterogeneity in type II Ehlers-Danlos syndrome. Br J Rheumatol. 1991 Jun;30(3):173–177. doi: 10.1093/rheumatology/30.3.173. [DOI] [PubMed] [Google Scholar]
  57. Xie R. L., Long G. L. Elements within the first 17 amino acids of human osteonectin are responsible for binding to type V collagen. J Biol Chem. 1996 Apr 5;271(14):8121–8125. doi: 10.1074/jbc.271.14.8121. [DOI] [PubMed] [Google Scholar]
  58. Yoshioka H., Greenwel P., Inoguchi K., Truter S., Inagaki Y., Ninomiya Y., Ramirez F. Structural and functional analysis of the promoter of the human alpha 1(XI) collagen gene. J Biol Chem. 1995 Jan 6;270(1):418–424. doi: 10.1074/jbc.270.1.418. [DOI] [PubMed] [Google Scholar]
  59. Yoshioka H., Iyama K., Inoguchi K., Khaleduzzaman M., Ninomiya Y., Ramirez F. Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). Dev Dyn. 1995 Sep;204(1):41–47. doi: 10.1002/aja.1002040106. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES